NCT00972738View on ClinicalTrials.gov

Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,214

Participants

Timeline

Start Date

April 30, 2001

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2001

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

montelukast sodium

Montelukast 10-mg tablet orally once daily at bedtime for 2 weeks.

DRUG

Comparator: loratadine

Loratadine 10-mg tablet orally once daily at bedtime for 2 weeks.

DRUG

Comparator: Placebo

placebo tablet orally once daily at bedtime for 2 weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00972738 - Montelukast in Seasonal Allergic Rhinitis - Spring 2001 Study (0476-235) | Biotech Hunter | Biotech Hunter